/Companies

Curve Therapeutics

3 known investors

Find your way into Curve Therapeutics

Sign up to see every warm intro you have to Curve Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Curve Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Curve Therapeutics uses its mammalian cell-based Microcycle discovery platform to develop cyclic peptide and small molecule drugs against intracellular targets. Its pipeline focuses on cancer, immunology, and inflammation.

Investors · 3

Related companies · 3

Companies working in the same space as Curve Therapeutics.

Frequently asked questions

What does Curve Therapeutics do?
Curve Therapeutics uses its mammalian cell-based Microcycle discovery platform to develop cyclic peptide and small molecule drugs against intracellular targets. Its pipeline focuses on cancer, immunology, and inflammation.
Who are Curve Therapeutics's investors?
Curve Therapeutics's investors include Epidarex Capital, Pfizer Venture Investments, Columbus Venture Partners.